Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-18

FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) filed by Astellas Pharma US, Inc. The approval adds to the existing approved uses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cresemba (isavuconazole)

Snippet

SUPPL AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)